Grantham, Mayo, Van Otterloo & Co (GMO)
CELG

Grantham, Mayo, Van Otterloo & Co (GMO)’s Celgene Corp CELG Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-729,700
Closed -$72.5M – 813
2019
Q3 		$72.5M Sell
729,700
-27,700
-4% -$2.63M 0.5% 41
2019
Q2 		$70M Buy
757,400
+751,800
+13,425% +$71.4M 0.49% 48
2019
Q1 		$528K Buy
+5,600
New +$490K ﹤0.01% 575
2017
Q4 		– Sell
-2,700
Closed -$394K – 665
2017
Q3 		$394K Sell
2,700
-300
-10% -$40.9K ﹤0.01% 437
2017
Q2 		$390K Buy
3,000
+1,100
+58% +$135K ﹤0.01% 431
2017
Q1 		$236K Buy
+1,900
New +$227K ﹤0.01% 483
2014
Q3 		– Sell
-50,000
Closed -$4.29M – 533
2014
Q2 		$4.29M Sell
50,000
-18,200
-27% -$1.38M 0.01% 290
2014
Q1 		$4.76M Sell
68,200
-105,644
-61% -$8.37M 0.01% 307
2013
Q4 		$14.7M Sell
173,844
-101,380
-37% -$8.02M 0.04% 173
2013
Q3 		$21.2M Buy
275,224
+70,246
+34% +$4.92M 0.06% 138
2013
Q2 		$12M Buy
+204,978
New +$12.3M 0.03% 188

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s CELG Position: Q4 2019 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 729,700 shares — an estimated $72.5M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CELG in Q2 2013 and held it in 11 quarters. The position peaked at $72.5M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 729,700 Celgene Corp shares in Q4 2019, an estimated $72.5M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Celgene Corp in Q2 2013 and held it in 11 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Celgene Corp position peaked at $72.5M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2019, filed 13 Feb 2020.